Murata M, Takahara E, Nagata O, Kato H, Tamai I and Tsuji A (1995) Carriermediated tissue distribution and pharmacokinetics of HSR-903, a new quinolone,
in Proceedings of the 35th Interscience Conference on Antimicrobial Agents and
Chemotherapy, F203, American Association for Microbiology, Washington, DC.
Murata M, Tamai I, Sai Y, Nagata O, Kato H and Tsuji A (1998) Hepatobiliary
transport of HSR-903, a new quinolone antibacterial agent. Drug Metab Dispos
26:1113–1119.
Ohnishi T, Tamai I, Sakanaka K, Sakata A, Yamashita T, Yamashita J and Tsuji A
(1995) In vivo and in vitro evidence for ATP-dependency of P-glycoproteinmediated efflux of doxorubicin at the blood-brain barrier. Biochem Pharmacol
49:1541–1544.
Ooie T, Suzuki H, Terasaki T and Sugiyama Y (1996a) Comparative distribution of
quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. J Pharmacol Exp Ther 278:590 –596.
Ooie T, Suzuki H, Terasaki T and Sugiyama Y (1996b) Characterization of the
transport properties of a new quinolone antibiotic, fleroxacin, in rat choroid plexus.
Pharm Res 13:523–527.
Ooie T, Terasaki T, Suzuki H and Sugiyama Y (1997) Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous
system. Drug Metab Dispos 25:784 –789.
Orsenigo MN, Tosco M and Faelli A (1992) Basolateral Cl-/HCO - exchange in rat
3

jejunum: Evidence from H14CO - uptake in membrane vesicles. Biochim Biophys
3

Acta 1108:140 –144.
Sakata A, Tamai I, Kawazu K, Deguchi Y, Ohnishi T, Saheki A and Tsuji A (1994)
In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of
cyclosporin A at the blood-brain barrier. Biochem Pharmacol 48:1989 –1992.
Schinkel AH, Smitt JJM, van Telligen O, Beijnen JH, Wagenaar E, van Deemter L,
Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM
and Borst P (1994) Disruption of mouse mdr1a P-glycoprotein leads to a deficiency
in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491–502.
Schwartz LR, Schwenk M, Pfaff E and Greim H (1977) Cholestatic steroid hormones
inhibited taurocholate uptake into isolated rat hepatocytes. Biochem Pharmacol
26:2433–2437.
Sugawara I, Nakahama M, Hamada H, Tsuruo T and Mori S (1988) Apparent
stronger expression in the human adrenal cortex than in the human adrenal
medulla of Mr 170000 –180000 P-glycoprotein. Cancer Res 48:4611– 4614.
Takahashi Y, Masuda N, Otsuki M, Miki M and Nishino T (1997) In vitro activity of
HSR-903, a new quinolone. Antimicrob Agents Chemother 41:1326 –1330.
Takasato Y, Rapoport SI and Smith Q (1984) An in situ brain perfusion technique to
study cerebrovascular transport in the rat. Am J Physiol 16:H484 –H493.
Tamai I, Senmaru M, Terasaki T and Tsuji A (1995) Na+ and Cl- transport of taurine
at the blood-brain barrier. Biochem Pharmacol 50:1783–1793.
Tamai I and Tsuji A (1996) Drug delivery through the blood-brain barrier. Adv Drug
Deliv Rev 19:401– 424.
